• Disease
  • Vertebral
  • Vertebral Fractures
  • Lisa Palermo

    Prominent publications by Lisa Palermo

    KOL Index score: 23564

    CONTEXT: Alendronate sodium reduces fracture risk in postmenopausal women who have vertebral fractures, but its effects on fracture risk have not been studied for women without vertebral fractures.

    OBJECTIVE: To test the hypothesis that 4 years of alendronate would decrease the risk of clinical and vertebral fractures in women who have low bone mineral density (BMD) but no vertebral fractures.

    DESIGN: Randomized, blinded, placebo-controlled trial.

    SETTING: Eleven community-based clinical ...

    Also Ranks for: Vertebral Fractures |  alendronate risk |  fracture intervention trial |  photon aged aged |  low bone
    KOL Index score: 19924

    CONTEXT: Type 2 diabetes mellitus (DM) is associated with higher bone mineral density (BMD) and paradoxically with increased fracture risk. It is not known if low BMD, central to fracture prediction in older adults, identifies fracture risk in patients with DM.

    OBJECTIVE: To determine if femoral neck BMD T score and the World Health Organization Fracture Risk Algorithm (FRAX) score are associated with hip and nonspine fracture risk in older adults with type 2 DM.


    Also Ranks for: Frax Score |  dm hip fracture |  type 2 |  neck bmd |  risk older
    KOL Index score: 18427

    CONTEXT: The optimal duration of treatment of women with postmenopausal osteoporosis is uncertain.

    OBJECTIVE: To compare the effects of discontinuing alendronate treatment after 5 years vs continuing for 10 years.

    DESIGN AND SETTING: Randomized, double-blind trial conducted at 10 US clinical centers that participated in the Fracture Intervention Trial (FIT).

    PARTICIPANTS: One thousand ninety-nine postmenopausal women who had been randomized to alendronate in FIT, with a mean of 5 years ...

    Also Ranks for: 5 Years |  fracture intervention trial |  risk women |  continuing alendronate |  biochemical markers
    KOL Index score: 17137

    The validity of the WHO 10-yr probability of major osteoporotic fracture model (FRAX) for prediction of vertebral fracture has not been tested. We analyzed how well FRAX for major osteoporotic fractures, with and without femoral neck BMD (FN BMD), predicted the risk of vertebral fracture. We also compared the predictive validity of FRAX, FN BMD, and prevalent vertebral fracture detected by radiographs at baseline alone or in combination to predict future vertebral fracture. We analyzed ...

    Also Ranks for: Vertebral Fracture |  frax bmd |  major osteoporotic |  predicted risk |  bone density
    KOL Index score: 16227

    The assessment of radiographs for vertebral fractures is important in the clinical evaluation of patients with suspected osteoporosis, in the epidemiological evaluation of elderly populations, and in clinical trials of osteotrophic drugs. The purpose of this study is to compare visual semiquantitative (SQ) approaches and quantitative morphometric approaches for assessing prevalent and incident vertebral fractures in postmenopausal osteoporosis. We analyzed lateral thoracolumbar spine ...

    Also Ranks for: Vertebral Fractures |  morphometric assessment |  quantitative morphometry |  prevalent incident |  evaluation studies
    KOL Index score: 16224

    The "PTH and Alendronate" or "PaTH" study compared the effects of PTH(1-84) and/or alendronate (ALN) in 238 postmenopausal, osteoporotic women. We performed finite element analysis on the QCT scans of 162 of these subjects to provide insight into femoral strength changes associated with these treatments and the relative roles of changes in the cortical and trabecular compartments on such strength changes. Patients were assigned to either PTH, ALN, or their combination (CMB) in year 1 and ...

    Also Ranks for: Finite Element Analysis |  femoral strength |  pth aln |  cortical trabecular |  1 year
    KOL Index score: 16165

    OBJECTIVE: To describe progression over 8 years in a community-based sample of elderly women with radiographic findings of hip osteoarthritis (RHOA) with or without hip pain.

    METHODS: Baseline and followup anteroposterior pelvic radiographs were obtained at a mean +/- SD 8.3 +/- 0.4 years of followup in women age > or =65 years at the baseline examination of the Study of Osteoporotic Fractures. We evaluated progression in 936 hips of 745 women with one or more baseline findings of RHOA: ...

    Also Ranks for: Radiographic Hip |  25 mm |  baseline followup |  elderly white women |  8 years
    KOL Index score: 15765

    Vertebral fractures in older women signal an increased risk of additional osteoporotic fractures. To identify risk factors for first vertebral fractures, we studied 5822 women > or =65 years of age who had no fracture on baseline radiographs of the spine. Several modifiable risk factors increased an older woman's risk of developing a first vertebral fracture, and women with multiple risk factors and low BMD had the highest risk. Risk factors and low BMD should be useful to help focus ...

    Also Ranks for: Vertebral Fracture |  bmd women |  65 years |  baseline radiographs |  factors increased
    KOL Index score: 15755

    It is commonly believed that the response to treatment in patients on alendronate is proportional to the increase in bone mineral density (BMD), and that those who lose BMD during treatment might not respond to treatment. In the Fracture Intervention Trial 6,459 women were randomly assigned to treatment with alendronate or placebo; BMD was measured annually, and new spine fractures were assessed by lateral spine films, taken at baseline and end of follow-up. Among subjects who took at ...

    Also Ranks for: Bmd Treatment |  bone density |  fracture intervention trial |  placebo women |  total hip
    KOL Index score: 15438

    CONTEXT: Bone marrow fat (BMF) and bone mineral density (BMD) by dual x-ray energy absorptiometry (DXA) are negatively correlated. However, little is known about the association of BMF with fracture or with separate trabecular and cortical bone compartments.

    OBJECTIVE: Our objective was to assess the relationships between vertebral BMF, BMD by quantitative computed tomography, and fracture in older adults.

    DESIGN, SETTING, AND PARTICIPANTS: We conducted a cross-sectional study in the Age ...

    Also Ranks for: Vertebral Bone |  bmf bmd |  marrow fat |  total hip |  quantitative computed tomography
    KOL Index score: 15318

    CONTEXT: The principle of "regression to the mean" predicts that patients with unusual responses to treatment might represent outliers who are likely to have more typical responses if treatment is continued without change.

    OBJECTIVE: To test whether women who lose bone mineral density (BMD) during the first year of treatment for osteoporosis continue to lose BMD if the same treatment is continued beyond 1 year.

    DESIGN AND SETTING: Two randomized, double-blind, placebo-controlled trials ...

    Also Ranks for: Bmd Treatment |  bone densitometry |  osteoporosis therapy |  2 years |  alendronate raloxifene
    KOL Index score: 15202

    BACKGROUND: Since the use of parathyroid hormone as a treatment for osteoporosis is limited to two years or less, the question of whether antiresorptive therapy should follow parathyroid hormone therapy is important. We previously reported results after the first year of this randomized trial comparing the use of full-length parathyroid hormone (1-84) alone, alendronate alone, or both combined. In the continuation of this trial, we asked whether antiresorptive therapy is required to ...

    Also Ranks for: Parathyroid Hormone |  alendronate therapy |  female fractures |  bone mineral density |  year 1
    KOL Index score: 15137

    CONTEXT: Treatment of osteoporotic women with PTH increases biochemical markers of bone turnover, increases axial bone mineral density (BMD), and reduces fracture risk.

    OBJECTIVE: Our objective was to determine the relationship between levels of baseline turnover before PTH therapy and short-term changes in turnover during PTH therapy and subsequent changes in areal and volumetric BMD.

    DESIGN AND SETTING: We conducted a randomized, placebo-controlled trial at four academic ...

    Also Ranks for: Postmenopausal Women |  bone turnover |  parathyroid hormone |  photon aged aged |  pth therapy
    KOL Index score: 15118

    A bone fractures only when loaded beyond its strength. The purpose of this study was to determine the association of femoral strength, as estimated by finite element (FE) analysis of dual-energy X-ray absorptiometry (DXA) scans, with incident hip fracture in comparison to hip bone mineral density (BMD), Fracture Risk Assessment Tool (FRAX), and hip structure analysis (HSA) variables. This prospective case-cohort study included a random sample of 1941 women and 668 incident hip fracture ...

    Also Ranks for: Femoral Strength |  dxa scans |  osteoporotic fractures |  incident hip fracture |  element analysis


    Lisa Palermo: Influence Statistics

    Sample of concepts for which Lisa Palermo is among the top experts in the world.
    Concept World rank
    steady age increments #1
    year age distribution #1
    686 95 population #1
    radiographically ascertained #1
    radiographic vertebral fractures #1
    bmd prevalent #1
    ascertained vertebral #1
    treatment alendronate #1
    mexican population year #1
    vertebral fractures mexican #1
    4 alendronate #1
    age frax #1
    resource infant #2
    effects respiratory outcomes #2
    pronosco posure #2
    ibandronate concurrent #2
    fracture objective #2
    women vertebral #2
    125 pounds #2
    surfactant rb #2
    treatment pth treatment #2
    trial higher costs #2
    bmd wrist #2
    spine fractures followup #2
    7782 women #2
    resource persistent #2
    dxa dxrbmd #2
    bmd dxrbmd #2
    risk spine fractures #2
    alendronate lose #2
    ” bmd #2
    vertebral fracture reduction #2
    alendronate bmd benefit #2
    postmenopausal predictive #2
    bmd vertebrae osteoporosis #2
    late surfactant effects #2
    deformities incident #2
    measurement kyphosis #2
    bmd year #2
    95 vertebral fractures #2
    persistent determined #2
    bmd 4 #2
    bmd lose #2

    Key People For Vertebral Fractures

    Top KOLs in the world
    Harry K Genant
    vertebral fractures rheumatoid arthritis postmenopausal women
    Michael C Nevitt
    knee pain osteoarthritis initiative cartilage loss
    Steven Ron Cummings
    hip fracture breast cancer older women
    Cyrus C Cooper
    hip fracture grip strength hertfordshire cohort study
    John A Kanis
    hip fracture postmenopausal women intervention thresholds
    Dennis M Black
    zoledronic acid hip fracture postmenopausal women

    Lisa Palermo:Expert Impact

    Concepts for whichLisa Palermohas direct influence:Vertebral fractures,  Vertebral fracture,  Fracture intervention trial,  Parathyroid hormone,  5 years,  Hip fracture,  Bone density,  Frax score.

    Lisa Palermo:KOL impact

    Concepts related to the work of other authors for whichfor which Lisa Palermo has influence:Vertebral fractures,  Postmenopausal women,  Hip fracture,  Bone mineral density,  Femoral neck,  Parathyroid hormone,  Lumbar spine.



    Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile

    Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA. | University of California, San Francisco San Francisco CA USA | Department of Epidemiology and Biostatistics, University of California San Franc